Literature DB >> 29280768

HIV Pre-exposure Prophylaxis Prescribing Through Telehealth.

Joanne D Stekler1, Vanessa McMahan, Lark Ballinger2, Luis Viquez2, Fred Swanson2, Jon Stockton3, Beth Crutsinger-Perry3, David Kern3,4, John D Scott.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29280768     DOI： 10.1097/QAI.0000000000001621

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  19 in total

Review 1.  The Current and Future Use of Telemedicine in Infectious Diseases Practice.

Authors:  Caitlin E Coombes; Megan E Gregory
Journal:  Curr Infect Dis Rep       Date:  2019-10-19       Impact factor: 3.725

2.  Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.

Authors:  Matthew A Spinelli; David V Glidden; Peter L Anderson; Monica Gandhi; Stephanie Cohen; Eric Vittinghoff; Megan E Coleman; Hyman Scott; Oliver Bacon; Richard Elion; Michael A Kolber; Susan P Buchbinder; Albert Y Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

3.  Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color.

Authors:  Sarah Wood; Robert Gross; Judy A Shea; José A Bauermeister; Joshua Franklin; Danielle Petsis; Meghan Swyryn; Linden Lalley-Chareczko; Helen C Koenig; Nadia Dowshen
Journal:  AIDS Behav       Date:  2019-10

Review 4.  The Potential of Telecommunication Technology to Address Racial/Ethnic Disparities in HIV PrEP Awareness, Uptake, Adherence, and Persistence in Care: A Review.

Authors:  Kimberly N Evans; Rashida Hassan; Ashley Townes; Kate Buchacz; Dawn K Smith
Journal:  AIDS Behav       Date:  2022-05-25

5.  Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs.

Authors:  Hansel E Tookes; Tyler S Bartholomew; Edward Suarez; Elisha Ekowo; Margaret Ginoza; David W Forrest; David P Serota; Allan Rodriguez; Michael A Kolber; Daniel J Feaster; Angela Mooss; Derek Boyd; Candice Sternberg; Lisa R Metsch
Journal:  Drug Alcohol Depend       Date:  2021-10-27       Impact factor: 4.852

6.  Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project.

Authors:  Matthew A Spinelli; David V Glidden; Warren C Rodrigues; Guohong Wang; Michael Vincent; Hideaki Okochi; Karen Kuncze; Megha Mehrotra; Patricia Defechereux; Susan P Buchbinder; Robert M Grant; Monica Gandhi
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

7.  Brief Report: PrEPTECH: A Telehealth-Based Initiation Program for HIV Pre-exposure Prophylaxis in Young Men of Color Who Have Sex With Men. A Pilot Study of Feasibility.

Authors:  Oliver N Refugio; Mabel M Kimble; Cara L Silva; James E Lykens; Christian Bannister; Jeffrey D Klausner
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

8.  Understanding PrEP Persistence: Provider and Patient Perspectives.

Authors:  Nicole D Laborde; Patrick M Kinley; Matthew Spinelli; Eric Vittinghoff; Ryan Whitacre; Hyman M Scott; Susan P Buchbinder
Journal:  AIDS Behav       Date:  2020-09

9.  A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation.

Authors:  Christine M Khosropour; Kandis V Backus; Arianna R Means; Laura Beauchamps; Kendra Johnson; Matthew R Golden; Leandro Mena
Journal:  AIDS Patient Care STDS       Date:  2020-01       Impact factor: 5.078

10.  Siegler et al. Respond.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss
Journal:  Am J Public Health       Date:  2020-01       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.